Instructions: UT System/TMC Member Reliance on IRB
Multiple UT campuses, as well as additional sites like and Texas Medical Center (TMC) institutions, have signed an IRB Reciprocity Agreement. The participating sites are:
UT Arlington | UT Austin | UT Dallas | UT El Paso | UT Permian Basin |
UT Rio Grande Valley | UT San Antonio | UT Tyler | UT Southwestern Medical Center | UT Health |
UT Medical Branch | UT Health Science Center San Antonio | UT MD Anderson | UT Health Science Center Tyler | Baylor College of Medicine |
Texas Tech University | Texas Tech University Health Sciences Center | Texas Tech University Health Sciences Center El Paso | Angelo State University | University of North Texas |
University of North Texas Health Science Center | Rice University | The Methodist Hospital System | Texas A&M University | 91ƽ |
Under this agreement, one of the above institutions can serve as the IRB of record (Reviewing IRB), and other institution(s) (Relying IRBs) can accept the review and approval of the IRB of record. Here is a brief description of the process required of investigators requesting for one of the above sites to rely on ’s IRB review:
- The Addition of a Site Investigator Form must be completed and signed by the relying site investigator and provided to the
IRB by emailing the IRB Office.
- The IRB office will confirm with the IRB at the relying site that they agree to
rely on the IRB. If so, the IRB will request necessary documents from the IRB
at the relying site. The IRB will also aid in negotiating any changes needed to
the relying site’s consent and/or assent templates if necessary.
-
Submit your protocol to the IRB for approval. Ideally, this is done in the initial application, but can also be added later by the submission of a modification to the protocol.
- The investigator must include information describing the activities of the relying
IRB in the protocol (relying site role, team member(s), locations, and any site-specific
recruitment materials/consent forms. Please follow these instructions for completing this submission.
- The IRB conducts its review; once all items have been addressed, an approval letter
will be issued.
- The PI provides the approval letter, protocol, consent forms and assent forms to
the relying site PI, who will provide them to their IRB office according to that institution’s
procedures.
- The investigator must promptly notify the relying site investigator upon:
- Notification that has renewed its approval at continuing review
- Any findings by of serious or continuing non-compliance
- Changes of the financial status of study team members that may require review for
conflict of interest
- Closure of the study
- Notification that has renewed its approval at continuing review
The external site relying on the IRB must provide the IRB with:
- Any management plan put in place by the external institution to manage a financial
conflict of interest related to the research project. This management plan must be
uploaded into the ICON protocol prior to IRB approval of the study (or using the “Create
Modification” activity of the interest is acquired during the course of the study).
- Any unanticipated events involving risk to subjects or others, or other issues of
noncompliance. These should be reported to the IRB using the “Report New Information”
activity in ICON.